Novel neutrophil agonists : oxidatively-fragmented phosphatidylcholines

Update Item Information
Title Novel neutrophil agonists : oxidatively-fragmented phosphatidylcholines
Publication Type dissertation
School or College College of Pharmacy
Department Pharmacology & Toxicology
Author Smiley, Patricia Louise
Date 1992-08
Description A variety of pathologic processes including ischemia and reperfusion-associated injury, Adult Respiratory Distress Syndrome, and chronic inflammation are associated with the sequestration and inappropriate activation of neutrophils (PMN). PMN contribute to tissue injury by degranulating to release of lytic components and by generating massive amounts of free radicals upon activation of the neutrophil respiratory burst. In addition to the activation of PMN, these pathologic processes are associated with the generation of reactive oxygen species, molecules that are efficient at modifying the structure of macromolecules, incuding cell membranes, proteins, and nucleic acids. Due to their abundance and susceptibility to oxidation, the polyunsaturated fatty acids present in the cell membrane phospholipids are primary targets for free radical-mediated oxidation, with subsequent peroxidation, bond rearrangement, degradation, and hydroxy lation. This dissertation presents data supporting the hypothesis that oxidative modification of membrane phospholipids may alter their structures so they are able to bind to and activate receptors present on the neutrophil surface for a potent phospholipid autocoid, platelet-activating factor (PAF). PAF mediates a variety of effects, including profound hypotension, increased vascular permeability, and activation of inflammatory cells. The model oxidatively-fragmented phospholipid, l-palmitoyl-2(-5-oxovaleroyl)-phosphatidylcholine was shown to stimulate neutrophil function through the PAF receptor. Additionally, oxidatively-fragmented phospholipids formed during unregulated oxidation of the phospholipid hydroperoxide, l-palmitoyl-2-(15-hydroperoxyeicosatetraenoyO-phosphatidylcholine were shown to exhibit PAF-like activity. One of these bioactive products was identified by gas chromatography/mass spectrometry as, l-paimitoyl-2-propionoyl-GPC, an oxidized phospholipid with an exceedingly short sn-2 residue. Additionally, bioactive compounds generated upon unregulated oxidation were substrates for the plasma PAF acetylhydrolase, an enzyme that circulates in whole blood and degrades phospholipids with short sn-2 residues, such as PAF. This enzyme may help limit the injury mediated by these phospholipids by ablating their activity should they occur in vivo. Finally, the cell membrane phospholipids of the neutrophils themselves may be targets for oxidative modification. Oxidized phosphatidylcholines with PAF-like bioactivity were generated upon peroxidation of the neutrophil cell membrane phospholipids. This activity was mediated by species with sn-\ ether linkages, although there actually apprears to be selective oxidation for PMN membrane phosphatidylcholines with sn-1 ester-linked residues.
Type Text
Publisher University of Utah
Subject Immunology
Subject MESH Neutrophils
Dissertation Institution University of Utah
Dissertation Name PhD
Language eng
Relation is Version of Digital reproduction of "Novel neutrophil agonists : oxidatively-fragmented phosphatidylcholines Spencer S. Eccles Health Sciences Library.
Rights Management © Patricia Louise Smiley.
Format application/pdf
Format Medium application/pdf
Format Extent 2,445,313 bytes
Identifier undthes,4091
Source Original: University of Utah Spencer S. Eccles Health Sciences Library (no longer available)
Funding/Fellowship Nora Eccles Tredwell Foundation; Grant 5T32 CA09602 from the National Cancer Institute; Grants HL35828 and HL44513 from the National Institutes of Health
Master File Extent 2,445,325 bytes
ARK ark:/87278/s6rv0qk8
Setname ir_etd
ID 191940
Reference URL https://collections.lib.utah.edu/ark:/87278/s6rv0qk8
Back to Search Results